138 related articles for article (PubMed ID: 15679947)
1. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
Bogdanos DP; Gilbert D; Bianchi I; Leoni S; Mitry RR; Ma Y; Mieli-Vergani G; Vergani D
J Autoimmune Dis; 2004 Nov; 1(1):4. PubMed ID: 15679947
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
[TBL] [Abstract][Full Text] [Related]
3. SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
Volkmann M; Luithle D; Zentgraf H; Schnölzer M; Fiedler S; Heid H; Schulze-Bergkamen A; Strassburg CP; Gehrke SG; Manns MP
J Autoimmun; 2010 Feb; 34(1):59-65. PubMed ID: 19683415
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis.
Costa M; Rodríguez-Sánchez JL; Czaja AJ; Gelpí C
Clin Exp Immunol; 2000 Aug; 121(2):364-74. PubMed ID: 10931155
[TBL] [Abstract][Full Text] [Related]
5. Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs.
Torres-Collado AX; Czaja AJ; Gelpí C
Liver Int; 2005 Apr; 25(2):410-9. PubMed ID: 15780067
[TBL] [Abstract][Full Text] [Related]
6. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
Volkmann M; Martin L; Bäurle A; Heid H; Strassburg CP; Trautwein C; Fiehn W; Manns MP
Hepatology; 2001 Mar; 33(3):591-6. PubMed ID: 11230739
[TBL] [Abstract][Full Text] [Related]
7. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection.
Vitozzi S; Lapierre P; Djilali-Saiah I; Marceau G; Beland K; Alvarez F
Autoimmunity; 2004 May; 37(3):217-22. PubMed ID: 15497455
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.
Radzimski C; Probst C; Teegen B; Rentzsch K; Blöcker IM; Dähnrich C; Schlumberger W; Stöcker W; Bogdanos DP; Komorowski L
Clin Dev Immunol; 2013; 2013():572815. PubMed ID: 23401700
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
[TBL] [Abstract][Full Text] [Related]
10. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
[TBL] [Abstract][Full Text] [Related]
11. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
[TBL] [Abstract][Full Text] [Related]
12. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
13. Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery.
Xu XM; Mix H; Carlson BA; Grabowski PJ; Gladyshev VN; Berry MJ; Hatfield DL
J Biol Chem; 2005 Dec; 280(50):41568-75. PubMed ID: 16230358
[TBL] [Abstract][Full Text] [Related]
14. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW
Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173
[TBL] [Abstract][Full Text] [Related]
15. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies.
Wächter B; Kyriatsoulis A; Lohse AW; Gerken G; Meyer zum Büschenfelde KH; Manns M
J Hepatol; 1990 Sep; 11(2):232-9. PubMed ID: 1701454
[TBL] [Abstract][Full Text] [Related]
16. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis.
Ballot E; Bruneel A; Labas V; Johanet C
Clin Chem; 2003 Apr; 49(4):634-43. PubMed ID: 12651817
[TBL] [Abstract][Full Text] [Related]
17. Induction of endothelial cell apoptosis by anti-alpha-enolase antibody.
Yang HB; Zheng WJ; Zhang X; Tang FL
Chin Med Sci J; 2011 Sep; 26(3):152-7. PubMed ID: 22207923
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques.
Muratori L; Cataleta M; Muratori P; Manotti P; Lenzi M; Cassani F; Bianchi FB
J Immunol Methods; 1995 Dec; 187(2):259-64. PubMed ID: 7499885
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
